Navigation Links
Tata Consultancy Services to Support Roche's Global Capacity Building Initiative
Date:9/4/2007

MUMBAI, India, Sept 4 /PRNewswire/ -- Tata Consultancy Services (TCS), (BSE: TCS.BO, NSE: TCS.NS), a leading IT services, business solutions and outsourcing firm and Roche, one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics headquartered in Basel, Switzerland, have announced a partnership to advance Roche's Global Capacity Building Initiative (GCBI).

This new initiative will provide services to a number of areas in Roche's development organization, including Clinical Data Management, Clinical Programming, Biostatistics and Drug Safety support. The aim of the collaboration between TCS and Roche is to create a flexible, scalable and high-quality partnership to support the demands of Roche's increasing drug pipeline.

Jean-Jacques Garaud, Global Head of Pharma Development at Roche, commented: "For Roche, it was key to find the best partner for our GCBI initiative and the collaboration with TCS is the result of an extensive international search. The partnership with TCS will allow us to address the growing operational needs of our Development organization and to handle the increasing workload".

G. L. Telang, Managing Director of Roche India, added: "Roche is pleased to have found a local partner in India which has the talents and know-how to support the company in this key initiative."

The partnership with TCS will help Roche to leverage the extensive talent pool in India, maximize synergies, and gain ongoing cost and process improvements, while maintaining high quality and service levels.

Located in Mumbai, the GCBI programme consists of a team of highly qualified pharmacologists, physicians, biostatisticians, pharmacists and informatics specialists. TCS will be working closely with Roche and contribute its strong domain expertise, talent management skills, flexible operating models, transition capabilities and performance-driven processes to the initiative.

Commenting
'/>"/>

SOURCE Tata Consultancy Services
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Queensland Opposition not happy over hiring consultancy
2. Reliance Infocomm Tied With Apollo To Provide Telemedicine Services
3. Support Services found to Dramatically Impact Pediatric Health Care
4. Mental Health Services for Children
5. London Emergency Services Receive Wide Appreciation
6. Health and Human Services stockpiles 20 million bird flu Vaccines
7. Mental Health Services In Poor Shape
8. The Cleveland Clinic Expands Its Services across the World via the Net
9. Medicare to cover services provided by rural health care personnels.
10. New Treat And Teach Program To Modernize Dental Services in Scotland
11. Shortage of services forces delayed hospital treatment for patient.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... When Ryan Bailey, a leader in hi...came to the leader in Refractive Surgery, Dr. Raje...scussion regarding his competitive lifestyle, time... specific eye parameters. Dr. Khanna then performe...us) November 23, 2009 -- Ryan Bailey won a silver ...
(Date:11/22/2009)... RSVfoundtocausefarmoreemergencydepartmentvisitsa...ov.23/PRNewswire-USNewswire/--Influenza,particular...ichealthofficials,themediaandthepublic.However,ana...sseeninitsemergencydepartment(ED)duringseveralrece...ytialvirus(RSV)-takesasubstantiallygreaterdiseaset...
(Date:11/22/2009)...AS Nov. 23, 2009 UT Southwestern Medical Center ...Institutes of Health to share $56 million over fiv...m (ICAC). , The ICAC, which receives funding th...Infectious Diseases, investigates novel treatments...becca Gruchalla, chief of allergy and immunology a...
(Date:11/22/2009)...INGTON, D.C. November 18, 2009 -- When people have...tes, which enter the body from the saliva of a mos...to red blood cells. Inside the blood cells, the pa...e proteins on the cell surface that change the phy...Experiments show that infected red blood cells are...
(Date:11/22/2009)...n can cause donated cells to attack recipient,s ti...(HealthDay News) -- Researchers are reporting that...he risk that someone who,s had a bone-marrow trans...sus-host disease. , The immune system-related ...nt has the variation and the donor does not. ,...
Breaking Medicine News(10 mins):Health News:Olympic Silver Medalist, Men's Water Polo Star Ryan Bailey Strikes Gold 2Health News:Amid the Flu Epidemic, Don't Forget RSV in Young Children 2Health News:Amid the Flu Epidemic, Don't Forget RSV in Young Children 3Health News:UT Southwestern receives continued NIH funding for Inner City Asthma Consortium 2Health News:Measuring and modeling blood flow in malaria 2
...fy E&Y and Approve Charter Amendment; ...ay 19 Ventas, Inc. (NYSE: VTR ),("Ventas" or the... declared,a regular quarterly dividend of $0.5125 ...,s 2008 annual dividend., STOCKHOLDERS APPROVE PR...
...d by Dr. Robert S. Bray, Jr. of ...9 Weightlifter Melanie Roach is living,her dream ...s Saturday in,Atlanta thanks to Dr. Robert S. Bray...tpatient microdiscectomy under a,high-powered Zeis...
...competitive,intelligence skills into the overall m...bout the market and competition. More than 70% of ... intelligence as an important,component of their g...n: Study Excerpt" (available at, http://www.best-i...
...ories,Inc. (Nasdaq: MLAB ) today reported record ...rch 31, 2008., Highlights: -- Annual revenue in...ncome increases 25% to a new record -- Annual net...ew record, Net sales for the fiscal year ended Ma...
...he National,Disaster Search Dog Foundation (SDF), ...ined canine-firefighter disaster search teams in t...lion 122-acre ranch site in Santa,Paula, Californi...emergency response network by training more teams ...
... advance knowledge of mysterious conditions , ...earch program designed to help patients with myste...s announced Monday by the U.S. National Institutes...ited States. The goals are to improve disease mana...
Other Medicine News:Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 2Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 3Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 4Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 5Health News:Successful Back Surgery Propels Olympic Weightlifting Hopeful Melanie Roach to Realize Her Dreams Of Participating in the 2008 Beijing Olympics 2Health News:Mesa Labs Reports Record Year End Sales and Earnings 2Health News:Mesa Labs Reports Record Year End Sales and Earnings 3Health News:Mesa Labs Reports Record Year End Sales and Earnings 4Health News:Mesa Labs Reports Record Year End Sales and Earnings 5Health News:Mesa Labs Reports Record Year End Sales and Earnings 6Health News:National Disaster Search Dog Foundation Plans New Training Facility in Santa Paula, California 2Health News:U.S. Turns Spotlight on Medicine's Most Puzzling Cases 2
(Date:11/20/2009)...rstCall/ -- Medco Health Solutions, Inc (NYSE: M...American healthcare through an advanced, wired pha...uality clinical care and fundamentally bending the...r the benefit of patients and payors alike. ,, ...s strategy enable "Smarter Medicine" to help addre...
(Date:11/20/2009)...e/ -- Reportlinker.com announces that a new market..., Global Self Monitoring Blood Glucose Market (... http://www.reportlinker.com/p0164657/Global-Self...g-Adoption-to-Drive-Growth.html#utm_source=prnewsw... ,, Description ,, Global Self Monitoring ...
(Date:11/20/2009)...e/ -- ,, Reportlinker.com announces that a new ...ue. ,, Global Markets for Breast Biopsy Device...41/Global-Markets-for-Breast-Biopsy-Devices-2009.h...m_campaign=prnewswire ,, The global markets f...d core needle market and vacuum assisted breast bi...
Breaking Medicine Technology:Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Imaging cuts in Medicare fee schedule 3A An access catastrophe and danger to patients 60552 1Imaging cuts in Medicare fee schedule 3A An access catastrophe and danger to patients 60552 2Imaging cuts in Medicare fee schedule 3A An access catastrophe and danger to patients 60552 3High throughput genotyping protein purification featured in Cold Spring Harbor Protocols 10608 1High throughput genotyping protein purification featured in Cold Spring Harbor Protocols 10608 2Engineering Careers for the Next Generation Nov 18 10605 1Engineering Careers for the Next Generation Nov 18 10605 2
...DA Submission in 2009, SEATTLE, March 25 Cell Th...nced today that enrollment is complete in,the phas... (BBR2278) for,patients with relapsed diffuse larg... of the data is expected in the second half of 200...nd Drug Administration (FDA) the data,could provid...
...if., March 24 NuRx,Pharmaceuticals, Inc. (OTC Bul...e first patient in a Phase I clinical trial of the...X4204., The single-center study, which NuRx expec... is designed to evaluate the safety and tolerabili... drug candidate in clinical,trials., "Our preclin...
Other Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 2Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 3Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 4NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204 2
Magnesium (Liquid)
LD Lactate –> Pyruvate
Rheumatoid Factor Latex Test (RF)
IgG (sample dilution, 1-shot only) (Liquid)
Medicine Products: